173 related articles for article (PubMed ID: 20525250)
1. Antisense oligonucleotide targeting Livin induces apoptosis of human bladder cancer cell via a mechanism involving caspase 3.
Liu C; Wu X; Luo C; Hu Z; Yin Z; He Y; Du H; Zhang W; Jiang Q; Lin Y
J Exp Clin Cancer Res; 2010 Jun; 29(1):63. PubMed ID: 20525250
[TBL] [Abstract][Full Text] [Related]
2. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment.
Liu HB; Kong CZ; Zeng Y; Liu XK; Bi JB; Jiang YJ; Han S
Urol Oncol; 2009; 27(3):277-83. PubMed ID: 18555709
[TBL] [Abstract][Full Text] [Related]
3. Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.
Wang Z; Liu S; Ding K; Ding S; Li C; Lu J; Gao D; Zhang T; Bi D
Tumour Biol; 2016 Nov; 37(11):15133-15143. PubMed ID: 27677286
[TBL] [Abstract][Full Text] [Related]
4. siRNA directed against Livin inhibits tumor growth and induces apoptosis in human glioma cells.
Yuan B; Ran B; Wang S; Liu Z; Zheng Z; Chen H
J Neurooncol; 2012 Mar; 107(1):81-7. PubMed ID: 22086237
[TBL] [Abstract][Full Text] [Related]
5. CYLD downregulates Livin and synergistically improves gemcitabine chemosensitivity and decreases migratory/invasive potential in bladder cancer: the effect is autophagy-associated.
Yin L; Liu S; Li C; Ding S; Bi D; Niu Z; Han L; Li W; Gao D; Liu Z; Lu J
Tumour Biol; 2016 Sep; 37(9):12731-12742. PubMed ID: 27448305
[TBL] [Abstract][Full Text] [Related]
6. Transfection with Livin and Survivin shRNA inhibits the growth and proliferation of non‑small cell lung cancer cells.
Huang Q; Zeng Y; Lin H; Zhang H; Yang D
Mol Med Rep; 2017 Nov; 16(5):7086-7091. PubMed ID: 28901499
[TBL] [Abstract][Full Text] [Related]
7. Impact of Co-transfection with Livin and survivin shRNA expression vectors on biological behavior of HepG2 cells.
Xu W; Chang H; Qin CK; Zhai YP
Asian Pac J Cancer Prev; 2013; 14(9):5467-72. PubMed ID: 24175843
[TBL] [Abstract][Full Text] [Related]
8. siRNA targeting Livin decreases tumor in a xenograft model for colon cancer.
Oh BY; Lee RA; Kim KH
World J Gastroenterol; 2011 May; 17(20):2563-71. PubMed ID: 21633662
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of the antiapoptotic factor Livin contributes to cisplatin resistance in colon cancer cells.
Ding ZY; Liu GH; Olsson B; Sun XF
Tumour Biol; 2013 Apr; 34(2):683-93. PubMed ID: 23188704
[TBL] [Abstract][Full Text] [Related]
10. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene.
Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P
Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791
[TBL] [Abstract][Full Text] [Related]
11. Suppression of livin gene expression by siRNA leads to growth inhibition and apoptosis induction in human bladder cancer T24 cells.
Yang D; Song X; Zhang J; Ye L; Wang S; Che X; Wang J; Zhang Z; Wang L
Biosci Biotechnol Biochem; 2010; 74(5):1039-44. PubMed ID: 20460713
[TBL] [Abstract][Full Text] [Related]
12. Inhibitor of apoptosis protein Livin promotes tumor progression and chemoradioresistance in human anaplastic thyroid cancer.
Kim HK; Kim SA; Jung EK; Lee KH; Lee JK; Kang HC; Joo YE; Lim SC; Yoon TM
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649820
[TBL] [Abstract][Full Text] [Related]
13. Livin contributes to tumor hypoxia-induced resistance to cytotoxic therapies in glioblastoma multiforme.
Hsieh CH; Lin YJ; Wu CP; Lee HT; Shyu WC; Wang CC
Clin Cancer Res; 2015 Jan; 21(2):460-70. PubMed ID: 25370472
[TBL] [Abstract][Full Text] [Related]
14. [Expression of livin in gastric cancer and effect of silencing of the livin gene on apoptosis in gastric cancer cells].
Liu P; Wang TS; You SH; Ge HM
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):570-4. PubMed ID: 18210873
[TBL] [Abstract][Full Text] [Related]
15. Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.
Altieri B; Sbiera S; Della Casa S; Weigand I; Wild V; Steinhauer S; Fadda G; Kocot A; Bekteshi M; Mambretti EM; Rosenwald A; Pontecorvi A; Fassnacht M; Ronchi CL
Oncotarget; 2017 Feb; 8(6):9323-9338. PubMed ID: 28030838
[TBL] [Abstract][Full Text] [Related]
16. Silencing Livin gene expression to inhibit proliferation and enhance chemosensitivity in tumor cells.
Wang R; Lin F; Wang X; Gao P; Dong K; Zou AM; Cheng SY; Wei SH; Zhang HZ
Cancer Gene Ther; 2008 Jun; 15(6):402-12. PubMed ID: 18340356
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of immunoglobulin G prompts cell proliferation and inhibits cell apoptosis in human urothelial carcinoma.
Liang PY; Li HY; Zhou ZY; Jin YX; Wang SX; Peng XH; Ou SJ
Tumour Biol; 2013 Jun; 34(3):1783-91. PubMed ID: 23483488
[TBL] [Abstract][Full Text] [Related]
18. [RNAi-mediated gene silencing of livin synergistic with epirubicin enhance apoptosis of human breast cancer cells].
Liang CY; Ma P; Liu XL
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1703-6. PubMed ID: 19024543
[TBL] [Abstract][Full Text] [Related]
19. [Effects of human Livin gene down-regulation by RNA interference on xenograft of transplantation tumor induced by SPC-A1 in nude mice].
Chen YS; Li YT; Li HR; Chen XY; Lin LF
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jan; 34(1):43-7. PubMed ID: 21429419
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of Livin inhibits growth and invasion of gastric cancer cells through blockade of the MAPK pathway in vitro and in vivo.
Ou JM; Ye B; Qiu MK; Dai YX; Dong Q; Shen J; Dong P; Wang XF; Liu YB; Quan ZW; Fei ZW
Int J Oncol; 2014 Jan; 44(1):276-84. PubMed ID: 24220265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]